Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects of childbearing potential must agree to use adequate contraception beginning at the signing informed consent form until at least  months after the last dose of study drug.
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Women of childbearing potential must have a negative serum pregnancy test performed within  days prior to the start of study drug; post-menopausal women (defined as no menses for at least  year) and surgically sterilized women are not required to undergo a pregnancy test; subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate but is generally defined as a hormonal or barrier method of birth control, or abstinence
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months for both females and males after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  days after the last dose of study drug; contraception can be either abstinence of penetrative intercourse, condom use, or prior vasectomy
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Women of childbearing potential and men must agree to use adequate contraception beginning at the signing of the consent until at least  weeks after the last dose of study drug
Women of childbearing potential and men must agree to use adequate contraception beginning at the signing of the consent until at least  months after the last dose of study drug
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Patients (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  days after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug. The definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate.
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the consent form until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Any of the following:\r\n* Pregnant women\r\n* Nursing women\r\n* Men or women of childbearing potential who are unwilling to employ adequate contraception\r\n** NOTE: men and women of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the consent form until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  days after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  days after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  days after the last dose of study drug. The definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate.
Subjects of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the ICF until at least  months after the last dose of study drug; highly effective contraception must be used (e.g. male condom with spermicidal, diaphragm with spermicidal, intra-uterine device) by both sexes
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; highly effective contraception must be used (e.g. male condom with spermicidal, diaphragm with spermicidal, intra-uterine device) must be used by both sexes
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at registration until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator
Willingness to use adequate methods of contraception beginning at the signing of the ICF until at least  days after the last dose of study drug
Subjects (men and women) of childbearing potential must agree to use adequate contraception beginning at the signing of the informed consent form (ICF) until at least  months after the last dose of study drug; the definition of adequate contraception will be based on the judgment of the principal investigator or a designated associate
